Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ATRC |
---|---|---|
09:32 ET | 2970 | 36.2 |
09:33 ET | 3795 | 36.21 |
09:35 ET | 234 | 36.33 |
09:37 ET | 570 | 36.5 |
09:39 ET | 300 | 36.445 |
09:44 ET | 200 | 36.34 |
09:46 ET | 300 | 36.34 |
09:50 ET | 546 | 36.385 |
09:51 ET | 300 | 36.495 |
09:53 ET | 200 | 36.395 |
09:55 ET | 400 | 36.41 |
10:00 ET | 100 | 36.47 |
10:02 ET | 1705 | 36.475 |
10:04 ET | 100 | 36.47 |
10:06 ET | 6342 | 36.845 |
10:08 ET | 3646 | 36.93 |
10:09 ET | 400 | 36.995 |
10:11 ET | 3065 | 37.09 |
10:13 ET | 900 | 37.11 |
10:15 ET | 4127 | 37.252 |
10:18 ET | 2555 | 37.11 |
10:20 ET | 1120 | 37.17 |
10:22 ET | 100 | 37.125 |
10:24 ET | 665 | 37.08 |
10:26 ET | 2547 | 36.93 |
10:27 ET | 800 | 36.93 |
10:29 ET | 200 | 36.96 |
10:31 ET | 100 | 36.96 |
10:33 ET | 200 | 36.965 |
10:36 ET | 1894 | 36.96 |
10:38 ET | 2200 | 36.92 |
10:40 ET | 800 | 36.9475 |
10:44 ET | 610 | 36.61 |
10:45 ET | 100 | 36.67 |
10:47 ET | 100 | 36.65 |
10:49 ET | 446 | 36.67 |
10:51 ET | 3306 | 36.65 |
10:54 ET | 1270 | 36.54 |
10:56 ET | 3100 | 36.56 |
10:58 ET | 996 | 36.525 |
11:00 ET | 1000 | 36.525 |
11:02 ET | 802 | 36.53 |
11:03 ET | 6404 | 36.58 |
11:05 ET | 1767 | 36.45 |
11:07 ET | 400 | 36.53 |
11:09 ET | 700 | 36.5 |
11:12 ET | 1391 | 36.45 |
11:14 ET | 600 | 36.45 |
11:16 ET | 402 | 36.38 |
11:18 ET | 100 | 36.32 |
11:20 ET | 5657 | 36.255 |
11:21 ET | 300 | 36.21 |
11:23 ET | 3000 | 36.215 |
11:25 ET | 2110 | 36.28 |
11:27 ET | 9162 | 36.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
AtriCure Inc | 1.8B | -43.5x | --- |
10X Genomics Inc | 1.8B | -10.3x | --- |
Novocure Ltd | 1.9B | -14.2x | --- |
Rxsight Inc | 1.9B | -56.6x | --- |
STAAR Surgical Co | 1.4B | 66.1x | +31.52% |
Alphatec Holdings Inc | 1.4B | -8.2x | --- |
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.8B |
---|---|
Revenue (TTM) | $447.6M |
Shares Outstanding | 48.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.40 |
EPS | $-0.83 |
Book Value | $9.81 |
P/E Ratio | -43.5x |
Price/Sales (TTM) | 3.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -7.94% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.